About The EAGLE Study
About EAGLE Study
This EAGLE research study is evaluating the investigational medication OM-85 for its safety and efficacy in the treatment of recurrent wheezing in children 6 months to 5 years of age. OM-85 is an oral capsule to be taken once daily. The capsule should be opened and its amount stirred into a small quantity of liquid.
OM-85 is designed for shaping the immune response to improve the body’s immune defense against respiratory tract infections, while at the same time preventing excessive inflammatory reactions in the lungs, both of which are involved in preschool wheezing.
Refer a Child
Does your child, or a relative between the ages of 6 months and 5 years, have recurrent wheezing? They may be eligible to participate in the study. Consider sharing information with their parents or legal representatives about how they can learn more.